Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujata Patil

Showing results (111-120 of 230) with videos related to

Pageof 23
Sort By:
Journal of Statistics and Data Science Education : an Official Journal of the of the American Statistical Association|March 31, 2025
<i>Virtual Biostats Day:</i> An interactive online Biostatistics outreach program directed at high school students in groups historically underrepresented in STEM careersEsther Drill, Jessica A Lavery, Stephanie Lobaugh, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 6, 2022
Effects of a Novel High-Quality Protein Infant Formula on Energetic Efficiency and Tolerance: A Randomized TrialDevon Kuehn, Steven H Zeisel, Diana F Orenstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumorsDarren R Feldman, Gopa Iyer, Lindsay Van Alstine, et al.
Investigational New Drugs|May 24, 2007
Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumorsDarren R Feldman, G Varuni Kondagunta, Michelle S Ginsberg, et al.
Cancer|April 23, 2013
Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and olderDarren R Feldman, Martin H Voss, Erin P Jacobsen, et al.
Breast Cancer Research and Treatment|September 8, 2011
Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancerDevika Gajria, Joseph Gonzalez, Kimberly Feigin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumorsJames E Korkola, Jane Houldsworth, Darren R Feldman, et al.
Cancer|January 27, 2009
Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapyUdo Rudloff, Edi Brogi, Julia P Brockway, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2013
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancerMary L Gemignani, Sujata Patil, Venkatraman E Seshan, et al.
BMC Women'S Health|March 16, 2025
Assessing the Impact of Lymphedema Therapy Referral on Breast Cancer Survivors' Lymphedema Knowledge: A Cross-Sectional SurveyMadelyn Klugman, Yashasvini Sampathkumar, Sujata Patil, et al.
Pageof 23

Showing results (111-120 of 230) with videos related to

Sort By:
Pageof 23
Journal of Statistics and Data Science Education : an Official Journal of the of the American Statistical Association|March 31, 2025
<i>Virtual Biostats Day:</i> An interactive online Biostatistics outreach program directed at high school students in groups historically underrepresented in STEM careersEsther Drill, Jessica A Lavery, Stephanie Lobaugh, et al.
Journal of Pediatric Gastroenterology and Nutrition|June 6, 2022
Effects of a Novel High-Quality Protein Infant Formula on Energetic Efficiency and Tolerance: A Randomized TrialDevon Kuehn, Steven H Zeisel, Diana F Orenstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2014
Presence of somatic mutations within PIK3CA, AKT, RAS, and FGFR3 but not BRAF in cisplatin-resistant germ cell tumorsDarren R Feldman, Gopa Iyer, Lindsay Van Alstine, et al.
Investigational New Drugs|May 24, 2007
Phase II trial of ixabepilone in patients with cisplatin-refractory germ cell tumorsDarren R Feldman, G Varuni Kondagunta, Michelle S Ginsberg, et al.
Cancer|April 23, 2013
Clinical features, presentation, and tolerance of platinum-based chemotherapy in germ cell tumor patients 50 years of age and olderDarren R Feldman, Martin H Voss, Erin P Jacobsen, et al.
Breast Cancer Research and Treatment|September 8, 2011
Phase II trial of a novel capecitabine dosing schedule in combination with lapatinib for the treatment of patients with HER2-positive metastatic breast cancerDevika Gajria, Joseph Gonzalez, Kimberly Feigin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2009
Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumorsJames E Korkola, Jane Houldsworth, Darren R Feldman, et al.
Cancer|January 27, 2009
Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapyUdo Rudloff, Edi Brogi, Julia P Brockway, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2013
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancerMary L Gemignani, Sujata Patil, Venkatraman E Seshan, et al.
BMC Women'S Health|March 16, 2025
Assessing the Impact of Lymphedema Therapy Referral on Breast Cancer Survivors' Lymphedema Knowledge: A Cross-Sectional SurveyMadelyn Klugman, Yashasvini Sampathkumar, Sujata Patil, et al.
Pageof 23